Pharvaris (PHVS) Cash from Operations (2025 - 2026)
Pharvaris posted quarterly Cash from Operations of 57092530.86 for Q1 2026, down 41.08% year-on-year from 96901332.11 in Q1 2025, and down 41.08% on a QoQ basis from 40467682.66 in Q1 2025.
Pharvaris (PHVS) has 2 years of Cash from Operations data on file, last reported at 57092530.86 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Pharvaris | 267.74 Mn | -73.74 Mn | - | -57.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.09 Mn |
| Mar 31, 2026 | -57.09 Mn |
| Mar 31, 2025 | -40.47 Mn |
| Mar 31, 2025 | -40.47 Mn |